Online Media Kit

FEATURED STORY

July 30, 2020 | Aidsmap (UK)

The vaginal ring against HIV: regulatory approval for a new prevention choice for women

The dapivirine ring is the first HIV prevention option specifically designed for women since the female condom was approved nearly 30 years ago. More »

FEATURED STORY

July 25, 2020 | SABC News (South Africa)

HIV Vaginal Ring

A vaginal ring has moved one step closer to becoming a new HIV prevention method for women in sub-Saharan Africa.  More »

FEATURED STORY

July 24, 2020 | Times LIVE (South Africa)

Vaginal ring gives women more options for HIV prevention

Access to a long-acting vaginal ring, which was tested in SA and showed promising results, is getting closer to reality after Europe’s regulatory body gave it the thumbs-up. More »

FEATURED STORY

February 26, 2016 | The New York Times editorial

Helping Women in Africa Avoid H.I.V.

Now, women in the developing world have new hope. The results of two major studies in Africa that were released Monday show that a new device could help protect women against H.I.V. More »

Media Highlights

July 28, 2020 | ZTN News (Zimbabwe)

Dapivirine Ring Provides Safe Sex For Women

The ring is inserted into the vagina and lasts for 28 days, providing protection against HIV. However, it does not protect one from sexually transmitted infections and pregnancy. More »

July 28, 2020 | UNAIDS

UNAIDS is hopeful that a new long-acting HIV prevention option will soon become available for women in sub-Saharan Africa

UNAIDS congratulates IPM on obtaining a positive opinion from the EMA on the dapivirine vaginal ring. The monthly ring adapts a medical technology commonly used as a contraceptive device to deliver... More »

July 28, 2020 | Life4me+ (Germany)

EMA empfiehlt Dapivirin-Vaginalring zum Schutz vor HIV

The EMA recommends approval for women over the age of 18 in combination with other safer sex practices. More »

July 28, 2020 | Deutsche Apotheker Zeitung (DAZ) (Germany)

Dapivirin-Vaginalring zum Schutz vor HIV-1

The CHMP advises that a dapivirine vaginal ring be approved in countries outside the EU. TThe ring is said to have reduced the infection rate by 35 percent in studies. More »

Pages